Microbiota and colorectal cancer: colibactin makes its mark

Nat Rev Gastroenterol Hepatol. 2020 Jun;17(6):317-318. doi: 10.1038/s41575-020-0303-y.

Author

Janelle C Arthur^{1

2

3}

Affiliations

¹ Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. janelle_arthur@med.unc.edu.
² Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. janelle_arthur@med.unc.edu.
³ Center for Gastrointestinal Biology and Disease, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. janelle_arthur@med.unc.edu.

PMID: 32317778
DOI: 10.1038/s41575-020-0303-y

No abstract available

Publication types

Comment

MeSH terms

Colorectal Neoplasms*
DNA Damage
Escherichia coli
Humans
Microbiota*
Peptides
Polyketides

Substances

Peptides
Polyketides
colibactin

Grants and funding